{"entity":{"type":"insider","cik":"0001895035","url":"/insider/0001895035","json_url":"/insider/0001895035.json","name":"Hsu Jason","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":7,"first":"2021-12-20","last":"2024-12-26","span_basis":"filed_date"},"name_variants":[{"name":"Hsu Jason","source":"filing","n_filings":7,"first_seen":"2021-12-20","last_seen":"2024-12-26"}],"transactions":[{"id":2867694,"accession":"0001493152-24-052103","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-24-052103","line_url":"/filing/0001493152-24-052103#line-2","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001895035","owner_name":"Hsu Jason","owner_display_name":"Hsu Jason","owner_url":"/insider/0001895035","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":2.192,"price_display":"2.19","price_state":"stated","total_value":87680.0,"total_display":"87,680.00","total_whole":"87,680","shares_owned_after":893000.0,"shares_owned_after_display":"893,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-23","filed_date":"2024-12-26","scope":"insider"},{"id":2867690,"accession":"0001493152-24-052103","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-052103","line_url":"/filing/0001493152-24-052103#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001895035","owner_name":"Hsu Jason","owner_display_name":"Hsu Jason","owner_url":"/insider/0001895035","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7700.0,"shares_display":"7,700","price_per_share":2.166,"price_display":"2.17","price_state":"stated","total_value":16678.2,"total_display":"16,678.20","total_whole":"16,678","shares_owned_after":853000.0,"shares_owned_after_display":"853,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-20","filed_date":"2024-12-26","scope":"insider"},{"id":3081587,"accession":"0001493152-24-033900","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-24-033900","line_url":"/filing/0001493152-24-033900#line-2","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001895035","owner_name":"Hsu Jason","owner_display_name":"Hsu Jason","owner_url":"/insider/0001895035","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8100.0,"shares_display":"8,100","price_per_share":2.251,"price_display":"2.25","price_state":"stated","total_value":18233.1,"total_display":"18,233.10","total_whole":"18,233","shares_owned_after":845300.0,"shares_owned_after_display":"845,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-22","filed_date":"2024-08-26","scope":"insider"},{"id":3081583,"accession":"0001493152-24-033900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-033900","line_url":"/filing/0001493152-24-033900#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001895035","owner_name":"Hsu Jason","owner_display_name":"Hsu Jason","owner_url":"/insider/0001895035","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":2.226,"price_display":"2.23","price_state":"stated","total_value":33390.0,"total_display":"33,390.00","total_whole":"33,390","shares_owned_after":837200.0,"shares_owned_after_display":"837,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-21","filed_date":"2024-08-26","scope":"insider"},{"id":2185998,"accession":"0001493152-24-029810","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-24-029810","line_url":"/filing/0001493152-24-029810#line-2","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001895035","owner_name":"Hsu Jason","owner_display_name":"Hsu Jason","owner_url":"/insider/0001895035","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":2.1462,"price_display":"2.15","price_state":"stated","total_value":12877.2,"total_display":"12,877.20","total_whole":"12,877","shares_owned_after":822200.0,"shares_owned_after_display":"822,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-24","filed_date":"2024-07-31","scope":"insider"},{"id":2185996,"accession":"0001493152-24-029810","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-029810","line_url":"/filing/0001493152-24-029810#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001895035","owner_name":"Hsu Jason","owner_display_name":"Hsu Jason","owner_url":"/insider/0001895035","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3200.0,"shares_display":"3,200","price_per_share":2.0748,"price_display":"2.07","price_state":"stated","total_value":6639.36,"total_display":"6,639.36","total_whole":"6,639","shares_owned_after":816200.0,"shares_owned_after_display":"816,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-18","filed_date":"2024-07-31","scope":"insider"},{"id":8556698,"accession":"0001493152-23-044618","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-23-044618","line_url":"/filing/0001493152-23-044618#line-2","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001895035","owner_name":"Hsu Jason","owner_display_name":"Hsu Jason","owner_url":"/insider/0001895035","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31000.0,"shares_display":"31,000","price_per_share":4.674,"price_display":"4.67","price_state":"stated","total_value":144894.0,"total_display":"144,894.00","total_whole":"144,894","shares_owned_after":813000.0,"shares_owned_after_display":"813,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-12","scope":"insider"},{"id":8556693,"accession":"0001493152-23-044618","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-044618","line_url":"/filing/0001493152-23-044618#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001895035","owner_name":"Hsu Jason","owner_display_name":"Hsu Jason","owner_url":"/insider/0001895035","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":4.881,"price_display":"4.88","price_state":"stated","total_value":122025.0,"total_display":"122,025.00","total_whole":"122,025","shares_owned_after":782000.0,"shares_owned_after_display":"782,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-08","filed_date":"2023-12-12","scope":"insider"},{"id":8020882,"accession":"0001493152-23-032969","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001493152-23-032969","line_url":"/filing/0001493152-23-032969#line-4","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001895035","owner_name":"Hsu Jason","owner_display_name":"Hsu Jason","owner_url":"/insider/0001895035","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":2.4852,"price_display":"2.49","price_state":"stated","total_value":17396.4,"total_display":"17,396.40","total_whole":"17,396","shares_owned_after":757000.0,"shares_owned_after_display":"757,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-15","filed_date":"2023-09-18","scope":"insider"},{"id":8020879,"accession":"0001493152-23-032969","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-23-032969","line_url":"/filing/0001493152-23-032969#line-3","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001895035","owner_name":"Hsu Jason","owner_display_name":"Hsu Jason","owner_url":"/insider/0001895035","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.5772,"price_display":"2.58","price_state":"stated","total_value":25772.0,"total_display":"25,772.00","total_whole":"25,772","shares_owned_after":750000.0,"shares_owned_after_display":"750,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-14","filed_date":"2023-09-18","scope":"insider"},{"id":8020877,"accession":"0001493152-23-032969","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-23-032969","line_url":"/filing/0001493152-23-032969#line-2","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001895035","owner_name":"Hsu Jason","owner_display_name":"Hsu Jason","owner_url":"/insider/0001895035","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":2.8288,"price_display":"2.83","price_state":"stated","total_value":84864.0,"total_display":"84,864.00","total_whole":"84,864","shares_owned_after":740000.0,"shares_owned_after_display":"740,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-12","filed_date":"2023-09-18","scope":"insider"},{"id":8020875,"accession":"0001493152-23-032969","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-032969","line_url":"/filing/0001493152-23-032969#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001895035","owner_name":"Hsu Jason","owner_display_name":"Hsu Jason","owner_url":"/insider/0001895035","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.8912,"price_display":"2.89","price_state":"stated","total_value":72280.0,"total_display":"72,280.00","total_whole":"72,280","shares_owned_after":710000.0,"shares_owned_after_display":"710,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-11","filed_date":"2023-09-18","scope":"insider"},{"id":8169168,"accession":"0001493152-23-032372","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-032372","line_url":"/filing/0001493152-23-032372#line-1","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001895035","owner_name":"Hsu Jason","owner_display_name":"Hsu Jason","owner_url":"/insider/0001895035","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.5317,"price_display":"2.53","price_state":"stated","total_value":25317.0,"total_display":"25,317.00","total_whole":"25,317","shares_owned_after":685000.0,"shares_owned_after_display":"685,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-08","filed_date":"2023-09-12","scope":"insider"},{"id":4478267,"accession":"0001493152-21-032039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-21-032039","line_url":"/filing/0001493152-21-032039#line-2","is_derivative":false,"issuer_cik":"0001873835","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001873835","owner_cik":"0001895035","owner_name":"Hsu Jason","owner_display_name":"Hsu Jason","owner_url":"/insider/0001895035","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-20","filed_date":"2021-12-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":14,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001873835","name":"Immix Biopharma, Inc.","url":"/issuer/0001873835","role":"Director","n_filings":7,"first_seen":"2021-12-20","last_seen":"2024-12-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001895035","retrieved_at":"2026-08-23T18:04:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}